New bipartisan bill aims to speed up clinical trials for rare disease treatments
A new bipartisan bill aims to speed rare disease drug development by making clinical trials faster, cheaper and more accessible to patients.
A new bipartisan bill aims to speed rare disease drug development by making clinical trials faster, cheaper and more accessible to patients. This story matters for Finance & Markets readers tracking fund. Reported by cnbc.com. Read the full original at the source link below.
Originally reported by cnbc.com. FundNews.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily fund signal